Refine
Document Type
- Article (12)
Language
- English (12)
Has Fulltext
- yes (12)
Is part of the Bibliography
- no (12)
Keywords
- - (6)
- CRISPR/Cas9 (4)
- cerebral cavernous malformation (4)
- Cerebral cavernous malformations (3)
- CRISPR/Cas9 genome editing (2)
- blood outgrowth endothelial cells (2)
- cerebral cavernous malformations (2)
- Angiogenesis (1)
- Animal models (1)
- CCM1 (1)
- CCM1/KRIT1 (1)
- CNV analyses (1)
- Cerebrovascular disease (1)
- Co-culture (1)
- DWI (1)
- Genetic counselling (1)
- Intracerebral haemorrhage (1)
- MRI (1)
- Molecular genetics (1)
- NSC59984 (1)
- Nd:YAG (1)
- Prevalence (1)
- RNA sequencing (1)
- RNA-Seq (1)
- Tumor-like behavior (1)
- Vascular malformation (1)
- ablation zone (1)
- biomarker (1)
- cerebral hemorrhage (1)
- copy number variants (1)
- diagnostic and predictive genetic analyses (1)
- endothelial-specific gene expression (1)
- experimental radiology (1)
- genetic counseling (1)
- hereditary breast and ovarian cancer (1)
- iPSC-derived endothelial cells (1)
- iPSCs (1)
- induced pluripotent stem cells (1)
- laser ablation (1)
- long-read sequencing (1)
- mutation correction (1)
- nanopore sequencing (1)
- neuroblastoma (1)
- novel (1)
- pathology (1)
- quantitative image analysis (1)
- risk-adapted prevention (1)
- rural area (1)
- seizures (1)
- structural variants (1)
- thermal ablation (1)
- transcript analyses (1)
- transcription start site (1)
- variant of unknown clinical significance (1)
- von Willebrand factor (1)
Institute
Publisher
- MDPI (5)
- Frontiers Media S.A. (3)
- S. Karger AG (2)
- Springer Nature (1)
- Wiley (1)
Based on the latest gnomAD dataset, the prevalence of symptomatic hereditary cerebral cavernous malformations (CCMs) prone to cause epileptic seizures and stroke-like symptoms was re-evaluated in this review and calculated to be 1:5,400-1:6,200. Furthermore, state-of-the-art molecular genetic analyses of the known CCM loci are described which reach an almost 100% mutation detection rate for familial CCMs if whole genome sequencing is performed for seemingly mutation-negative families. An update on the spectrum of CCM1, CCM2, and CCM3 mutations demonstrates that deep-intronic mutations and submicroscopic copy-number neutral genomic rearrangements are rare. Finally, this review points to current guidelines on genetic counselling, neuroimaging, medical as well as neurosurgical treatment and highlights the formation of active patient organizations in various countries.